Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue (GHS). It is currently under investigation for its ability to activate the ghrelin receptor (GHS-R1a) and stimulate endogenous growth hormone (GH) release in preclinical models. Notably, Ipamorelin demonstrates minimal impact on cortisol and prolactin levels, making it a valuable tool in studies of pituitary signaling, anabolic pathways, and endocrine regulation. This compound is provided strictly for laboratory research purposes and is not approved for human or veterinary use
Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue (GHS). It is currently under investigation for its ability to activate the ghrelin receptor (GHS-R1a) and stimulate endogenous growth hormone (GH) release in preclinical models. Notably, Ipamorelin demonstrates minimal impact on cortisol and prolactin levels, making it a valuable tool in studies of pituitary signaling, anabolic pathways, and endocrine regulation. This compound is provided strictly for laboratory research purposes and is not approved for human or veterinary use
